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OBJECTIVES We investigated the prognostic significance of exercise-induced silent myocardial ischemia in
both high and low risk men with no prior coronary heart disease (CHD).
BACKGROUND Silent ischemia predicts future coronary events in patients with CHD, but there is little
evidence of its prognostic significance in subjects free of CHD.
METHODS We investigated the association of silent ischemia, as defined by ST depression during and
after maximal symptom-limited exercise test, with coronary risk in a population-based sample
of men with no prior CHD followed for 10 years on average.
RESULTS Silent ischemia during exercise was associated with a 5.9-fold (95% CI 2.3 to 11.8) CHD
mortality in smokers, 3.8-fold (95% CI 1.9 to 7.9) in hypercholesterolemic men and 4.7-fold
(95% CI 2.4 to 9.1) in hypertensive men adjusting for other risk factors. The respective
relative risks (RRs) of any acute coronary event were 3.0 (95% CI 1.7 to 5.1), 1.9 (95% CI
1.2 to 3.1) and 2.2 (95% CI 1.4 to 3.5). These associations were weaker in men without these
risk factors. Furthermore, silent ischemia after exercise was a stronger predictor for the risk
of acute coronary events and CHD death in smokers and in hypercholesterolemic and
hypertensive men than in men without risk factors.
CONCLUSIONS Exercise-induced silent myocardial ischemia was a strong predictor of CHD in men with any
conventional risk factor, emphasizing the importance of exercise testing to identify asymp-
tomatic high risk men who could benefit from risk reduction and preventive measures. (J Am
Coll Cardiol 2001;38:72–9) © 2001 by the American College of Cardiology
Exercise-induced myocardial ischemia is known to increase
the risk of future coronary events not only in patients with
coronary heart disease (CHD) (1–6) but also in individuals
with no prior CHD (7). Some studies (2,4) have indicated
that symptomatic ischemia is a stronger risk factor for future
coronary events, whereas other studies (3,5,6) have sug-
gested that silent ischemia has a similar prognostic value in
these patients. However, there are few if any data showing
that silent ischemia during and after exercise would have
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long-term prognostic significance with regard to coronary
risk in persons without CHD (7). The likelihood to detect
myocardial ischemia by exercise testing in asymptomatic
individuals is known to rise with increasing pretest proba-
bility of CHD (7–10). Nonetheless, little is known about
the prognostic value of exercise-induced silent ischemia in
high risk individuals. Therefore, we investigated the prog-
nostic significance of silent myocardial ischemia during and
after exercise with regard to the risk of acute coronary events
and coronary death in a population-based sample of middle-
aged men with no prior CHD. Furthermore, we explored if
smoking, serum low density lipoprotein (LDL) cholesterol
and systolic blood pressure (SBP) modify these associations.
METHODS
Subjects. The subjects were participants in the Kuopio
Ischemic Heart Disease risk factor (KIHD) study. This
study was designed to investigate previously unestablished risk
factors for cardiovascular disease (CVD), carotid atherosclero-
sis and related outcomes in a population-based sample of men
from eastern Finland (11). Of the 3,433 men aged 42, 48, 54
or 60 years who resided in the town of Kuopio or its
surrounding rural communities, 198 were excluded because of
death, serious disease or migration. Of the remainder, 2,682
(83%) participated in the study. Baseline examinations were
conducted between March 1984 and December 1989.
Men who had prevalent CHD at the baseline (n 5 888)
and for whom exercise stress test was not performed due to
severe CVD or some other disease (n 5 25) were excluded
from the study. Prevalent CHD was defined as either a
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history of myocardial infarction or angina pectoris, angina
pectoris on effort based on the London School of Hygiene
Cardiovascular Questionnaire (12), the use of nitroglycerin
for chest pain once a week or more frequently or chest pain
as a cause of stopping exercise stress test at baseline. Thus,
the present study is based on 1,769 men who had complete
data on electrocardiographic recordings during and after
exercise.
Exercise stress test. A maximal symptom-limited exercise
stress test was performed using an electrically braked bicycle
ergometer between 8:00 AM and 12:00 AM. For 407 men
(23%) examined before June 1986, the testing protocol
comprised of a 3-min warm-up at 50 W followed by a
step-by-step increase in the workload by 20 W/min (Tun-
turi EL 400 bicycle ergometer, Turku, Finland). The
remaining 1,362 men (77%) were tested with a linear
increase in the workload of 20 W/min (Medical Fitness
Equipment 400 L bicycle ergometer, Mearn, the Nether-
lands). Maximal oxygen uptake was measured directly using
a respiratory gas analyzer, as explained previously (13). Also,
heart rate and blood pressure were registered during the
exercise test.
The most common reasons for stopping the exercise test
were leg fatigue (1,021 men), exhaustion (298 men), breath-
lessness (245 men), and pain in the leg muscles, joints, or
back (77 men). The test was discontinued because of
cardiorespiratory symptoms or abnormalities for 120 men.
These included arrhythmias (60 men), marked changes in
systolic or diastolic blood pressure (44 men), dizziness (9
men) or ischemic electrocardiographic changes (7 men).
Exercise-induced ventricular conduction disorders were ob-
served in 5 men, one of who also had silent myocardial
ischemia during exercise but not during recovery.
Exercise electrocardiography. Electrocardiography was
recorded continuously with the Kone 620 electrocardio-
graph (Kone, Turku, Finland). The Mason-Likar lead
system including Vl, V5 and aVF lead connections was used
(14). An electrocardiogram (ECG) was printed in 30-s
intervals during exercise and at least 5 min during recovery
while the subject was sitting on the bicycle. Exercise ECGs
were coded manually by one cardiologist (J.E.).
Silent myocardial ischemia during exercise and after
5 min of recovery was defined as ischemia in the ECG
without typical chest pain indicating CHD. The criteria for
ischemia in ECG during exercise and recovery were hori-
zontal or downsloping ST depression $1.0 mm at 80 ms
after J point or any ST depression of .1.0 mm at 80 ms
after J point.
Assessment of other risk factors. The collection of blood
specimens (15) and the measurement of serum lipids and
lipoproteins (16) have been described elsewhere. Assess-
ment of smoking, alcohol consumption and blood pressure
was carried out as described previously (13,15). Body mass
index (BMI) was computed as the ratio of weight in
kilograms divided by the square of height in meters.
Collection and Classification of Follow-up Events
Acute coronary events. The collection of data on and the
diagnostic classification of nonfatal and fatal coronary events
by the end of 1992 were carried out as a part of the
multinational World Health Organization-Monitoring of
Trends and Determinants in Cardiovascular Diseases
(WHO-MONICA) project, in which detailed information
of all coronary events and strokes were collected prospec-
tively (17). At baseline, all KIHD participants lived in the
province of Kuopio, one of the monitoring areas of the
Finnish part of the WHO-MONICA project (FIN-
MONICA) (18). In the FINMONICA study, regional
coronary register teams collected data on coronary events
from hospitals and wards of health centers and classified the
events, as explained in detail previously (18). The sources of
information were interviews, hospital documents, death
certificates, autopsy reports and medico-legal reports. The
diagnostic classification of coronary events was based on
symptoms, electrocardiographic findings, cardiac enzyme
elevations, autopsy findings and history of CHD. Each
suspected coronary event (International Classification of
Disease [ICD]-9 codes 410-414 and ICD-10 codes I20-
I25) was classified into: 1) a definite acute myocardial
infarction (AMI); 2) a probable AMI; 3) a typical acute
chest pain episode of .20 min indicating CHD; 4) an
ischemic cardiac arrest with successful resuscitation; 5) no
acute coronary event; or 6) an unclassifiable fatal case. The
FINMONICA coronary register data were annually cross-
checked with the data obtained from the computerized
national hospital discharge and death registers. Data on
nonfatal and fatal coronary events from the beginning of
1993 to the end of 1997 were obtained by computer linkage
to the national hospital discharge and death certificate
registers. An internist (T.A.L.) collected and classified the
coronary events using the same procedures as in the FIN-
MONICA study (18). Definite AMIs, probable AMIs and
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prolonged chest pain episodes were used as outcome events.
All chest pain episodes lead to hospitalization. If a subject
had multiple nonfatal coronary events during the follow-up,
the first was considered the end point. The average
follow-up time to the first coronary event was 10.2 years
(range 0.7 to 13.8 years). Of all 174 coronary events, 91
were definite AMIs, 54 were probable AMIs and 29 were
typical acute chest pain episodes leading to hospitalization
and 8 of these typical chest pain episodes later led to AMI.
CHD deaths. Deaths were ascertained by computer link-
age to the national death registry using the patient’s social
security number. There were no losses to follow-up. All
deaths that occurred by the end of 1997 were included.
Cardiovascular disease and CHD deaths were coded using
to the ninth ICD codes (390-459 and 410-414, respectively)
or the tenth ICD codes (I00-I99 and I20-I25, respectively).
The average follow-up time to CHD death or the end of
follow-up was 10.5 years (range 0.3 to 13.8 years). In the
present sample, there were 77 CVD deaths, 53 of which
were due to CHD.
Statistical analysis. Differences in baseline variable be-
tween men with and without silent myocardial ischemia
during exercise were analyzed using Student’s t test. The
associations of silent myocardial ischemia during exercise
and recovery with the risk of acute coronary events and
CHD death were analyzed using risk factor adjusted Cox
proportional hazards models. The cumulative incidence of
acute coronary events and mortality from CHD by the
presence of silent myocardial ischemia was calculated using
the Kaplan-Meier method. The modification of the prog-
nostic value of silent myocardial ischemia by the major
CHD risk factors was analyzed by comparing smokers and
nonsmokers, men with higher ($3.9 mmol/l, median) and
lower (,3.9 mmol/l) serum LDL cholesterol and men
with higher ($132.3 mm Hg, median) and lower
(,132.3 mm Hg) SBP. Four men who used cholesterol-
lowering drugs were excluded from the analyses comparing
men with higher and lower serum LDL cholesterol levels,
and 269 men who used antihypertensive drugs were ex-
cluded from the analysis comparing men with higher and
lower SBP. If possible, confounding factors were entered
uncategorized into the Cox models. Relative hazards, ad-
justed for risk factors, were estimated as antilogarithms of
coefficients for independent variables. Their confidence
intervals (CI) were projected under the assumption of
asymptotic normality of the estimates. All tests for statistical
significance were two-sided. A p value of ,0.05 was
considered significant. All statistical analyses were per-
formed using SPSS 9.0 for Windows (SPSS Inc., Chicago,
Illinois).
RESULTS
Baseline characteristics. Baseline characteristics in men
with and without silent ischemia during exercise are shown
in Table 1. Serum LDL cholesterol, SBP and maximal heart
rate were higher and BMI was lower in men with silent
myocardial ischemia during exercise ischemia. Similar dif-
ferences were observed in men with and without silent
ischemia after exercise except for maximal oxygen uptake
(p 5 0.01) that was higher in men without silent ischemia
after exercise.
Strongest coronary risk factors. The strongest risk factors
for acute coronary events were smoking (p , 0.001),
diabetes (p , 0.001), low maximal oxygen uptake (p 5
0.002), high serum LDL cholesterol (p 5 0.003), low serum
high density lipoprotein (HDL) cholesterol (p 5 0.004) and
elevated SBP (p 5 0.01). The strongest risk factors for
CHD death were smoking (p , 0.001), low maximal
oxygen uptake (p , 0.001), elevated SBP (p 5 0.004) and
high BMI (p 5 0.006).




Men With Silent Ischemia
During Exercise
(n 5 189) p Value for
Statistical
SignificanceMean (SD)
Age (yrs) 52.2 (5.3) 52.7 (5.2) 0.17
Body mass index (kg/m2) 26.8 (3.4) 26.0 (3.1) 0.002
Smokers (%) 30.2 27.1 0.36
Cigarette smoking (pack-years*) 7.99 (16.2) 5.91 (13.1) 0.05
Alcohol consumption (g/week) 76.3 (119.9) 63.9 (84.5) 0.07
Diabetes (%) 4.0 4.2 0.87
Serum LDL cholesterol (mmol/l) 3.99 (0.99) 4.15 (0.94) 0.02
Serum HDL cholesterol (mmol/l) 1.31 (0.30) 1.30 (0.27) 0.83
Systolic blood pressure (mm Hg) 133.6 (16.0) 137.3 (17.4) 0.006
Diastolic blood pressure (mm Hg) 89.1 (10.3) 88.6 (10.3) 0.6
Resting heart rate (beats/min) 62 (11) 62 (10) 0.78
Maximal heart rate (beats/min) 160 (21) 165 (17) 0.001
Maximal oxygen uptake (ml/kg/min) 31.8 (7.5) 32.1 (7.4) 0.61
*Pack-years denotes the lifelong exposure to smoking which was estimated as the product of years smoked and the number of
tobacco products smoked daily at the time of examination (15).
HDL 5 high density lipoprotein; LDL 5 low density lipoprotein.
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Silent ischemia at baseline. There were 189 (10.7%) men
with silent ischemia during exercise and 54 (3.1%) men with
silent ischemia after exercise. Silent ischemia during exercise
was observed in 9.6% (n 5 51) of smokers, in 12.3% (n 5
110) of hypercholesterolemic men and in 12.4% (n 5 107)
of hypertensive men. Silent ischemia after exercise was
found in 2.8% (n 5 15) of smokers, in 3.3% (n 5 30) of
hypercholesterolemic men and in 4.0% (n 5 35) of hyper-
tensive men.
Number of coronary events during follow-up. Twenty-
nine (15.3%) of 189 men with silent ischemia during
exercise and 145 (9.2%) of 1,580 men without silent
ischemia had an acute coronary event during follow-up. The
respective numbers (percentages) for CHD death were 15
(7.9%) and 38 (2.4%). Thirteen (7.5%) of 54 men with
silent ischemia during recovery and 161 (2.6%) of 1,715
men without silent ischemia had an acute coronary event
during follow-up. The respective numbers (percentages) for
CHD death were 8 (15.1%) and 46 (2.7%).
Relative risk of coronary events in men with silent
ischemia. Men with silent ischemia during exercise had a
1.7-fold risk of acute coronary events and a 3.5-fold risk of
CHD death compared with men without silent ischemia
after adjusting for conventional risk factors (Table 2). Silent
ischemia after exercise was associated with a 2.3-fold risk of
acute coronary events and a 4.7-fold risk of CHD death
(Table 2). The cumulative hazard curves for CHD death
continued to diverge during the follow-up period (Fig. 1).
Silent ischemia during exercise and recovery were also
statistically and significantly associated with increased CVD
mortality (Table 2). In addition, milder silent ischemia
(defined as horizontal or downsloping ST depression 0.5 to
0.9 mm) after exercise was related to the risk of acute
coronary events (relative risk [RR] 5 1.8, 95% CI 1.0 to 3.0,
p 5 0.047) and CHD death (RR 5 3.8, 95% CI 1.8 to 8.0,
p , 0.004) but not during exercise.
Interactions of silent ischemia with conventional coro-
nary risk factors. Silent ischemia during exercise had a
stronger association with the risk of acute coronary events in
smokers, hypercholesterolemic men and hypertensive men
than in men without such risk factors (Fig. 2A). Silent
ischemia during exercise also had a stronger association with
the risk of CHD death in these risk groups (Fig. 2B). Silent
ischemia after exercise had a strong association with the risk
of acute coronary events (RR 5 3.5, 95% CI 1.6 to 3.5 for
smokers, RR 5 3.3, 95% CI 1.7 to 6.5 for hypercholester-
olemic men and RR 5 3.4, 95% CI 1.8 to 6.4 for
hypertensive men) and CHD death (RR 5 5.0, 95% CI 2.1
to 11.9 for smokers, RR 5 7.6, 95% CI 3.0 to 19.5 for
hypercholesterolemic men and RR 5 6.7, 95% CI 2.9 to
16.0 for hypertensive men) in men with any risk factor (Fig.
2C and D). All of these associations were statistically
nonsignificant in men without any conventional risk factors,
expect for nonsmokers with silent ischemia after exercise
who also had an increased risk of CHD death (RR 5 2.7,
95% CI 1.1 to 6.3, p 5 0.02).
DISCUSSION
Principal findings. The present prospective study demon-
strates that silent myocardial ischemia during exercise and
recovery, as indicated by ST depression in an ECG, predicts
acute coronary events and CHD death in middle-aged men
with no prior CHD. Our study emphasizes the independent
prognostic value of exercise-induced silent myocardial isch-
emia with regard to coronary risk. A very important finding
was that exercise-induced silent myocardial ischemia was a
stronger predictor of CHD in men with an unfavorable
coronary risk factor profile, i.e., in smokers, hypercholester-
olemic men and hypertensive men.
Previous studies and our findings. Unrecognized myocar-
dial ischemia is a common finding and increases the risk of
future coronary events (19,20). In our study, we observed
that painless myocardial ischemia during exercise was
present in 10.7% of men. Ischemic ST depression in the
absence of pain has been more common than ST depression
with angina in daily life (20–22). Some studies have shown
that the more frequent or progressive the anginal symptoms
are, the poorer the prognosis will be in patients with CHD
(2,4,23). Other studies have indicated that symptomatic and
silent ischemia are related to a similar prognosis in patients
with symptomatic (3,5,6) and mildly symptomatic CHD
(5). As patients become increasingly selected toward a
higher a priori likelihood of developing myocardial ischemia
and CHD, there appears to be a tendency for chest pain to
lose its significance as an additional predictive factor (23).
The prognostic value of silent myocardial ischemia, as
indicated by exercise ECG findings, varies considerably in
the published reports (2,7,10,24,25), most likely due to
different selection criteria for the subjects. Most studies have
included only patients with CHD (3,5,6), whereas few
studies have included persons without prior CHD (10,26).
Table 2. Risk of Acute Coronary Events and Coronary and CVD Death According to the Presence of Silent Myocardial Ischemia in
an Exercise Electrocardiogram in Men Without Prior Coronary Heart Disease
Risk Factor
Acute Coronary Events† Coronary Death CVD Death
RR (95% CI) p Value RR (95% CI) p Value RR (95% CI) p Value
Silent myocardial ischemia during exercise* 1.71 (1.14–2.56) 0.009 3.51 (1.90–6.50) ,0.001 3.26 (1.93–5.52) ,0.001
Silent myocardial ischemia during recovery* 2.34 (1.31–4.19) 0.005 4.71 (2.09–10.6) ,0.001 3.67 (1.81–7.46) ,0.001
*Each variable was entered separately into a Cox model with age, examination years, cigarette smoking, systolic blood pressure, alcohol consumption, body mass index, maximal
oxygen uptake, diabetes and serum low density lipoprotein and high density lipoprotein cholesterol. †Included 91 definite and 54 possible acute myocardial infarction and 29
typical chest pain episodes (angina pectoris) of .20 min leading to hospitalization. CI 5 confidence interval; CVD 5 cardiovascular disease; RR 5 relative risk.
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It has been argued that the prognostic value of exercise
ECG is low in totally asymptomatic persons because of
false-positive and false-negative responders. However, in
healthy individuals with a high pretest probability of CHD
(e.g., in those with major coronary risk factors), the fre-
quency of false-positive test responses for myocardial isch-
emia is lower than in those without coronary risk factors,
which diminishes the bias associated with false-positive
responders (the Bayes’ rule) (7,27). This could be one
explanation for our finding that the association between
silent myocardial ischemia with coronary risk was stronger
in high risk groups.
Electrocardiographic recordings not only during exercise
but also after exercise may improve the sensitivity of exercise
testing to detect myocardial ischemia. However, very few
studies have provided evidence that ischemic ST depression
after exercise would have an adverse prognostic value with
regard to coronary events in apparently healthy men (28–
31). We found that silent ischemic ECG findings that
prolonged or developed during recovery were associated
with increased risk of both acute coronary events and CHD
death. Interestingly, silent myocardial ischemia during re-
covery was even a stronger predictor of future events than
silent myocardial ischemia during exercise, especially with
regard to coronary death. This suggests that silent myocar-
dial ischemia during the postexercise period could be of
great clinical importance, and the prognostic value of
exercise testing can be improved by assessing ischemic ECG
changes during recovery.
Interactions with conventional risk factors. It has been
suggested that risk assessment for primary CHD is en-
hanced by the detection of abnormal exercise ECG findings
only in those who had one or more conventional risk factor
(7). However, there is no previous evidence that silent
myocardial ischemia would have greater predictive value in
high risk individuals. In the present study, men with silent
Figure 1. Cumulative hazards of coronary mortality in men with silent myocardial ischemia (high risk group) during exercise (A) and after exercise (B)
versus all others (low risk group).
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myocardial ischemia had a substantially increased risk of
CHD, especially if they had any conventional risk factor.
Interestingly, coronary mortality was very high in men with
silent ischemia during recovery and any of these risk factors.
These findings emphasize the importance of exercise testing
in screening individuals free of clinical CHD but who have
any of the major coronary risk factors and treated with
therapeutic preventive measures.
Mechanisms. Our findings suggest that exercise-induced
silent myocardial ischemia is a stronger predictor of fatal
than nonfatal coronary events or any coronary event in
healthy middle-aged men with no prior CHD. Consistent
with these findings, some previous studies have suggested
that silent myocardial ischemia is a pathophysiologic mech-
anism through which exercise increases the occurrence of
sudden death (9,22,32). One explanation for this could be
that painless ischemia increases the susceptibility to myo-
cardial infarction, left ventricular dysfunction and, ulti-
mately fatal ventricular arrhythmias. The transient impair-
ment of coronary flow during and after exercise may be
caused by dynamic coronary stenosis as a result of epicardial
coronary constriction, endothelial dysfunction, spasm and
thrombosis (21,22,33). Such brief episodes may be painless
because the stimulus is either inadequate or the pain usually
appears quite late after the onset of ischemia (20,23). One
mechanism for silent myocardial ischemia after exercise is
the rapid decline in diastolic blood pressure during recovery,
which reduces the myocardial perfusion pressure gradient
and transiently impairs subendocardial blood flow (29,31).
Furthermore, ischemic ST depression during recovery may
be due to elevated levels of plasma catecholamines during
the postexercise period, which could enhance myocardial
oxygen demand (30,34,35).
Methodologic considerations. One of the explanations for
the stronger associations between silent ischemia and coro-
nary risk in men with conventional risk factors may be that
ST depression is more likely due to true ischemia in these
men than in those with no risk factors. Better quality of
ECG recording after exercise may be one reason for the
stronger association of silent ischemia after exercise with
Figure 2. The relative risks (RR) (95% confidence intervals) of acute coronary events (A) and coronary death (B) in men with silent myocardial ischemia
during exercise, and the RRs of acute coronary events (C) and coronary death (D) in men with silent ischemia after exercise according to conventional risk
factor levels. Men without myocardial ischemia were a reference group. Cut-off for systolic blood pressure was 132 mm Hg and for serum low density
lipoprotein cholesterol 3.9 mmol/l. Adjusted for age, examination years, alcohol consumption, body-mass index, maximal oxygen uptake, diabetes, cigarette
smoking, systolic blood pressure and serum low density lipoprotein and high density lipoprotein cholesterol, except the risk factor of interest.
77JACC Vol. 38, No. 1, 2001 Laukkanen et al.
July 2001:72–9 Silent Myocardial Ischemia and Coronary Events
coronary risk. Although we observed that milder silent ST
depression after exercise may increase the risk of CHD, our
main findings are based on conventional criteria for isch-
emia, as false-positive test results may lead to psychological
and work disability as well as unnecessary medical expense
(27,36). The use of a smaller ST depression tends to
attenuate the specificity of the ischemic findings since
factors other than myocardial ischemia, such as hyperven-
tilation, electrolyte abnormalities, anemia, ventricular hy-
pertrophy and increased sympathetic activity, are known to
cause ST depression (10,24). One limitation of the present
study is that we were able to study only middle-aged men
and, thus, our findings may be not generalized to elderly and
female populations. Furthermore, there are more accurate
methods for assessing silent myocardial ischemia than ex-
ercise ECG, such as exercise and pharmacologic echocar-
diogram, myocardial perfusion imaging, positron emission
tomography and ambulatory ECG monitoring (27,37), but
as an easily available and inexpensive method exercise ECG
is suitable for population studies and in everyday clinical
practice.
Implications. The present findings are important from the
public health and preventive cardiology viewpoint. Silent
exercise-induced myocardial ischemia was common in
middle-aged men with no prior CHD, and it was associated
with a greater increased risk of CHD, especially in smokers,
hypercholesterolemic men and hypertensive men. This
study emphasizes the importance of identifying high risk
persons (by exercise testing) in greatest need of preventive
measures. The main clinical implication of our findings is
that painless myocardial ischemia is of significant additional
prognostic value when any conventional risk factors are
present in men clinically free of CHD.
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